CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | ALEXANDER SUSAN H EVP Chief Legal Officer | Option exercise · Restricted Stock Unit | −2,190 | 4,380 | ||
| 2024-02-08 | Gregory Ginger EVP, Human Resources | Option exercise | +1,635 | 10,117.72 | ||
| 2024-02-08 | Gregory Ginger EVP, Human Resources | Shares withheld for taxes | −498 | $240.30 | $120K | 9,619.72 |
| 2024-02-08 | Gregory Ginger EVP, Human Resources | Option exercise · Restricted Stock Unit | −1,635 | 3,270 | ||
| 2024-02-08 | Izzar Rachid Head of Global Product Strat. | Option exercise | +2,043 | 8,187 | ||
| 2024-02-08 | Izzar Rachid Head of Global Product Strat. | Shares withheld for taxes | −621 | $240.30 | $149K | 7,566 |
| 2024-02-08 | Izzar Rachid Head of Global Product Strat. | Option exercise · Restricted Stock Unit | −2,043 | 4,087 | ||
| 2024-02-08 | Kramer Robin Chief Accounting Officer | Option exercise | +788 | 4,942.75 | ||
| 2024-02-08 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −253 | $240.30 | $61K | 4,689.75 |
| 2024-02-08 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −788 | 1,577 | ||
| 2024-02-08 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +2,335 | 15,063 | ||
| 2024-02-08 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −765 | $240.30 | $184K | 14,298 |
| 2024-02-08 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,335 | 4,670 | ||
| 2024-02-08 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +2,101 | 7,894.99 | ||
| 2024-02-08 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −638 | $240.30 | $153K | 7,256.99 |
| 2024-02-08 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −2,101 | 4,204 | ||
| 2024-02-07 | ALEXANDER SUSAN H EVP Chief Legal Officer | Grant or award · Restricted Stock Unit | +5,820 | 5,820 | ||
| 2024-02-07 | Gregory Ginger EVP, Human Resources | Grant or award · Restricted Stock Unit | +5,405 | 5,405 | ||
| 2024-02-07 | Grogan Jane Head of Research | Grant or award · Restricted Stock Unit | +4,155 | 4,155 | ||
| 2024-02-07 | Izzar Rachid Head of Global Product Strat. | Grant or award · Restricted Stock Unit | +5,405 | 5,405 |
Page 18 of 29 · 579 trades